Total Payments
$9,791
2024 Payments
$2,303
Companies
35
Transactions
561
Medicare Patients
687
Medicare Billing
$57,654
Payment Breakdown by Category
Food & Beverage$9,499 (97.0%)
Consulting$260.00 (2.7%)
Education$31.27 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,499 | 559 | 97.0% |
| Consulting Fee | $260.00 | 1 | 2.7% |
| Education | $31.27 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,286 | 142 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $1,460 | 68 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,183 | 104 | $0 (2024) |
| Janssen Biotech, Inc. | $1,030 | 57 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,017 | 57 | $0 (2024) |
| QOL Medical, LLC | $296.37 | 12 | $0 (2024) |
| Celgene Corporation | $289.68 | 19 | $0 (2024) |
| PFIZER INC. | $255.44 | 17 | $0 (2024) |
| EVOKE PHARMA, INC. | $202.72 | 8 | $0 (2024) |
| GENZYME CORPORATION | $196.38 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,303 | 120 | ABBVIE INC. ($471.77) |
| 2023 | $3,192 | 184 | NESTLE HEALTHCARE NUTRITION INC. ($608.13) |
| 2022 | $2,418 | 134 | Nestle HealthCare Nutrition Inc. ($570.85) |
| 2021 | $1,878 | 123 | AbbVie Inc. ($809.78) |
All Payment Transactions
561 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.30 | General |
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | Cash or cash equivalent | $29.86 | General |
| Category: Antibiotic | ||||||
| 12/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.41 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/21/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Immunology | ||||||
| 11/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/13/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.10 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Immunology | ||||||
| 10/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $28.34 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.43 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 153 | 160 | $38,388 | $12,186 |
| 2022 | 5 | 190 | 203 | $52,644 | $15,290 |
| 2021 | 4 | 174 | 188 | $49,352 | $16,008 |
| 2020 | 3 | 170 | 186 | $51,806 | $14,170 |
Total Patients
687
Total Services
737
Medicare Billing
$57,654
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 54 | $15,432 | $4,360 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,500 | $2,243 | 29.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 22 | 22 | $3,850 | $1,992 | 51.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 36 | $7,006 | $1,802 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,600 | $1,789 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 81 | $23,148 | $6,137 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $13,200 | $4,344 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 45 | $8,757 | $2,680 | 30.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $4,200 | $1,252 | 29.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 12 | $3,338 | $877.06 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 87 | $24,863 | $7,368 | 29.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $13,500 | $5,061 | 37.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 39 | $7,589 | $2,394 | 31.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $3,400 | $1,185 | 34.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 88 | 103 | $29,435 | $6,921 | 23.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 59 | 59 | $17,700 | $6,107 | 34.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 24 | $4,670 | $1,143 | 24.5% |
About Sandra Bernklau, APRN-BC
Sandra Bernklau, APRN-BC is a Family healthcare provider based in Naperville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1790821882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Bernklau, APRN-BC has received a total of $9,791 in payments from pharmaceutical and medical device companies, with $2,303 received in 2024. These payments were reported across 561 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,499).
As a Medicare-enrolled provider, Bernklau has provided services to 687 Medicare beneficiaries, totaling 737 services with total Medicare billing of $57,654. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Naperville, IL
- Active Since 01/29/2007
- Last Updated 01/15/2026
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1790821882
Products in Payments
- ZENPEP (Drug) $1,331
- ENTYVIO (Biological) $885.58
- XIFAXAN (Drug) $860.76
- STELARA (Biological) $810.60
- RINVOQ (Biological) $569.24
- HUMIRA (Biological) $523.82
- SKYRIZI (Biological) $326.04
- TRULANCE (Drug) $321.78
- ZEPOSIA (Drug) $289.68
- LINZESS (Drug) $287.82
- VIBERZI (Drug) $276.52
- DUPIXENT (Biological) $272.08
- VOWST (Biological) $266.18
- XELJANZ (Drug) $255.44
- SUCRAID (Drug) $244.53
- MAVYRET (Drug) $239.84
- GIMOTI (Drug) $202.72
- MYRISK (Device) $176.83
- DIFICID (Drug) $163.41
- TREMFYA (Drug) $157.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Naperville
Erin Sieber, Np, NP
Family — Payments: $245,407
Family $245,407
Mrs. Melissa Toulios, Apn, APN
Family — Payments: $9,492
Family $9,492
Rachel Sulfridge
Family — Payments: $7,910
Family $7,910
Emily Schnurstein, Apn, APN
Family — Payments: $5,750
Family $5,750
Michelle Dela Pena, Aprn, Fnp, APRN, FNP
Family — Payments: $4,646
Family $4,646
Anju Kallan, Apn, APN
Family — Payments: $4,441
Family $4,441